JP2008510701A5 - - Google Patents

Download PDF

Info

Publication number
JP2008510701A5
JP2008510701A5 JP2007527975A JP2007527975A JP2008510701A5 JP 2008510701 A5 JP2008510701 A5 JP 2008510701A5 JP 2007527975 A JP2007527975 A JP 2007527975A JP 2007527975 A JP2007527975 A JP 2007527975A JP 2008510701 A5 JP2008510701 A5 JP 2008510701A5
Authority
JP
Japan
Prior art keywords
methoxyphenyl
chlorophenyl
methylphenyl
phenyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007527975A
Other languages
English (en)
Japanese (ja)
Other versions
JP5042833B2 (ja
JP2008510701A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/029259 external-priority patent/WO2006023562A2/en
Publication of JP2008510701A publication Critical patent/JP2008510701A/ja
Publication of JP2008510701A5 publication Critical patent/JP2008510701A5/ja
Application granted granted Critical
Publication of JP5042833B2 publication Critical patent/JP5042833B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007527975A 2004-08-19 2005-08-17 マクロファージエラスターゼの阻害剤としての5−[3−(4−ベンジルオキシフェニルチオ)−フラ−2−イル]−イミダゾリジン−2,4−ジオン及び類似体 Expired - Fee Related JP5042833B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60273604P 2004-08-19 2004-08-19
US60/602,736 2004-08-19
PCT/US2005/029259 WO2006023562A2 (en) 2004-08-19 2005-08-17 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2, 4-dione and analogues as inhibitors of macrophage elastase

Publications (3)

Publication Number Publication Date
JP2008510701A JP2008510701A (ja) 2008-04-10
JP2008510701A5 true JP2008510701A5 (enExample) 2008-10-02
JP5042833B2 JP5042833B2 (ja) 2012-10-03

Family

ID=35968136

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007527975A Expired - Fee Related JP5042833B2 (ja) 2004-08-19 2005-08-17 マクロファージエラスターゼの阻害剤としての5−[3−(4−ベンジルオキシフェニルチオ)−フラ−2−イル]−イミダゾリジン−2,4−ジオン及び類似体

Country Status (16)

Country Link
US (1) US7179831B2 (enExample)
EP (1) EP1789036B1 (enExample)
JP (1) JP5042833B2 (enExample)
KR (1) KR101197325B1 (enExample)
CN (1) CN101014338B (enExample)
AT (1) ATE508744T1 (enExample)
AU (1) AU2005277432B2 (enExample)
BR (1) BRPI0514470B8 (enExample)
CA (1) CA2577430C (enExample)
DK (1) DK1789036T3 (enExample)
ES (1) ES2364068T3 (enExample)
MX (1) MX2007001940A (enExample)
NZ (1) NZ553258A (enExample)
RU (1) RU2391339C2 (enExample)
SI (1) SI1789036T1 (enExample)
WO (1) WO2006023562A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007084486A2 (en) * 2006-01-13 2007-07-26 Battelle Memorial Institute Animal model for assessing copd-related diseases
EP2907512A1 (en) 2014-02-14 2015-08-19 Commissariat A L'energie Atomique Et Aux Energies Alternatives Inhibitors of MMP-12 as antiviral Agents
DK3503885T3 (da) * 2016-08-19 2022-06-20 Foresee Pharmaceuticals Co Ltd Farmaceutisk præparat og fremgangsmåder til anvendelse heraf
US10532102B2 (en) * 2016-08-19 2020-01-14 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition and methods of uses
EP3517531B1 (en) * 2016-09-23 2021-02-24 Kaken Pharmaceutical Co., Ltd. Method for producing (r)-5-(3,4-difluorophenyl)-5-[(3-methyl-2-oxopyridin-1(2h)-yl)methyl]imidazolidine-2,4-dione and intermediate for producing same
SG11202011318QA (en) * 2018-05-15 2020-12-30 Foresee Pharmaceuticals Usa Inc Matrix metalloproteinase (mmp) inhibitors and methods of use thereof
DK4058437T3 (da) 2019-11-14 2025-01-20 Foresee Pharmaceuticals Usa Inc Matrix-metalloproteinase-(MMP)-inhibitorer og fremgangsmåder til anvendelse heraf
WO2022261624A1 (en) * 2021-06-08 2022-12-15 Foresee Pharmaceuticals Co., Ltd. Safe administration of mmp-12 inhibitor
RU2766551C1 (ru) * 2021-07-19 2022-03-15 Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" (ПГНИУ) 5-(4-хлорфенил)-3-((4-хлорфенил)амино)-5-(фенилтио)фуран-2(5н)-он, обладающий противомикробной активностью

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352976B1 (en) * 1998-12-31 2002-03-05 Aventis Pharmaceuticals Inc. Selective inhibitors of MMP-12
CA2356689A1 (en) 1998-12-31 2000-07-13 Michael J. Janusz 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12
RU2150469C1 (ru) * 1999-06-01 2000-06-10 Уфимский государственный нефтяной технический университет Способ получения 2-(фурил-2)-1,3-имидазолидинов
AU4882101A (en) 2000-04-28 2001-11-12 Shionogi & Co., Ltd. Mmp-12 inhibitors
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
JP2004535411A (ja) 2001-05-25 2004-11-25 ブリストルーマイヤーズ スクイブ カンパニー マトリックスメタロプロテナーゼ及び/またはTNF−α転換酵素(TACE)の阻害剤としてのヒダントイン及び関連複素環化合物
EP1394159A1 (fr) * 2002-08-13 2004-03-03 Warner-Lambert Company LLC Nouveaux dérivés de thiophène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
GB0219896D0 (en) 2002-08-27 2002-10-02 Bayer Ag Dihydropyridine derivatives
AU2003282920A1 (en) 2002-10-04 2004-05-04 Bristol-Myers Squibb Company Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
US7132432B2 (en) * 2003-06-05 2006-11-07 Bristol-Myers Squibb Company Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)

Similar Documents

Publication Publication Date Title
JP2006526031A5 (enExample)
JP2009519226A5 (enExample)
JP2007500753A5 (enExample)
JP2007510619A5 (enExample)
JP2009501198A5 (enExample)
JP2005538089A5 (enExample)
JP2005517666A5 (enExample)
JP2007522220A5 (enExample)
JP2005112864A5 (enExample)
JP2009535462A5 (enExample)
JP2010515731A5 (enExample)
JP2007533752A5 (enExample)
JP2010536766A5 (enExample)
JP2008534636A5 (enExample)
JP2002527414A5 (enExample)
JP2004517813A5 (enExample)
JP2012507535A5 (enExample)
JP2008510701A5 (enExample)
JP2007502817A5 (enExample)
JP2010508310A5 (enExample)
JP2008520662A5 (enExample)
JP2013544854A5 (enExample)
JP2009539874A5 (enExample)
JP2006510659A5 (enExample)
JP2007536285A5 (enExample)